Picture of Bicycle Therapeutics logo

BCYC Bicycle Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Bicycle Therapeutics PLC reports results for the quarter ended in March - Earnings Summary

* Bicycle Therapeutics PLC  BCYC.OQ  reported a quarterly
adjusted
loss of 62 cents​​ per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of $-1.30.  The mean expectation of eleven analysts
for the quarter was for a loss of $1.24 per share. Wall Street
expected results to range from $-1.40 to $-1.03 per share.
    * Revenue rose 298.9% to $19.53 million from a year ago;
analysts
expected $6.03 million. 
    * Bicycle Therapeutics PLC's reported EPS for the quarter
was a
loss of 62 cents​.
    * The company reported a quarterly loss of $26.56 million.
    * Bicycle Therapeutics PLC shares had fallen by 2.8% this
quarter and gained 33.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.2%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Bicycle
Therapeutics PLC is $41.50 
This summary was machine generated from LSEG data May 2 at 05:04
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -1.24          -0.62          Beat
 Dec. 31 2023      -1.23          -1.16          Beat
 Sep. 30 2023      -1.17          -1.26          Missed
 Jun. 30 2023      -1.29          -1.41          Missed

Recent news on Bicycle Therapeutics

See all news